Assertio, Lupin, Bausch Must Face Buyers' Price-Fixing Suit

By Kevin Stawicki · March 6, 2020, 6:43 PM EST

A California federal judge has refused to dismantle a lawsuit alleging Bausch Health Co. and other pharmaceutical companies violated federal antitrust law by blocking a generic version of diabetes drug Glumetza...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Related Sections

Case Information

Case Title

In Re Glumetza Antitrust Litigation

Case Number

3:19-cv-05822

Court

California Northern

Nature of Suit

Anti-Trust

Date Filed

September 18, 2019